OTLK - Outlook Therapeutics stock climbs 13% amid Chardan upgrade
2024-02-15 14:52:59 ET
More on Outlook Therapeutics
- Outlook stock rallies on private placement, FDA study agreement
- Outlook Therapeutics GAAP EPS of -$0.24
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
- Financial information for Outlook Therapeutics